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Abstract: Animal and genetic studies point towards a role of metabotropic glutamate receptor
subtype 5 (mGluR5) in the pathophysiology of schizophrenia, but direct evidence from
postmortem schizophrenia studies have been inconsistent. We thus assessed mGluR5 protein
levels in samples of human post-mortem dorsolateral prefrontal cortex (DLPFC; n=37) and
hippocampal cornu ammonis 1 (CA1; cohort subset: n=20) from schizophrenia and matched
controls. We also measured the mGluR5 signaling partners, Norbin (neurochondrin), Tamalin
(GRASP1), and Preso1 (FRMPD4), which modulate mGluR5 trafficking, localization and
recycling. To determine if current antipsychotics influence mGluR5 and mGluR5 signaling
partners, lifetime antipsychotic history was correlated with protein measures in postmortem
samples. Protein levels were additionally analyzed in rats chronically treated with haloperidol
or olanzapine. mGluR5 protein levels were consistently increased in both the DLPFC (22%;
p<0.001) and CA1 (42%; p<0.001) of schizophrenia subjects compared to controls. mGluR5
signaling partners exhibited brain-region dependent alterations, with reductions in the
DLPFC (Norbin 37%, p<0.001; Tamalin 30%, p=0.040; Preso1 29%, p=0.001) and increases
in CA1 (Norbin 47%, p<0.001; Tamalin 34%, p=0.009; Preso1 83%, p<0.001). There were
no effects of current antipsychotics on mGluR5, Norbin, Tamalin or Preso1 in humans or
rats. In this study, we provide the first evidence that mGluR5 is increased and mGluR5
signaling partners are differentially altered in two highly important brain regions for
schizophrenia. The present findings thus support that mGluR5 regulation is altered in
schizophrenia, and that the identified changes in mGluR5, Norbin, Tamalin and Preso1
expression are unaffected by current therapeutics.

